X4 Pharmaceuticals, Inc.
XFOR
|
$1.31
4.8%
4.58%
2.2M
|
Health Technology
(0.0% 1d) (35.4% 1m) (5.9% 1y) (0.0% 2d) (0.0% 3d) (2.5% 7d) (-61.48% volume)
Earnings Calendar: 2024-03-26
Market Cap: $ 219,998,493
http://www.x4pharma.com
Sec Filling | Patents | 58 employees
(US) X4 Pharmaceuticals, Inc. operates as a biotechnology company, which engages in developing human antibodies for treating infectious diseases. The company focuses on restoring healthy immune system function by developing novel therapeutics for the treatment of rare diseases. Its products in pipeline include X4P-001, X4P-002, and X4P-003. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan and is headquartered in Cambridge, MA.
antibody infectious disease msa treatment
add to watch list Paper trade email alert is off
Press-releases
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 2.96%
H: 14.75%
C: 5.76%
nasdaq pharmaceuticals grants
X4 Pharmaceuticals to Participate in Upcoming April Investor Conferences
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 2.11%
H: 0.0%
C: 0.0%
pharmaceuticals
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-21 (Crawled : 10:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 0.98%
H: 28.16%
C: 27.18%
update pharmaceuticals financial results
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: -0.31%
H: 0.31%
C: -4.93%
conference report year pharmaceuticals financial results
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07 (Crawled : 12:00) - prnewswire.com
PFE A | $25.69 -0.85% 0.1% 29M
|
Health Technology
|
| O: 0.04%
H: 0.44%
C: -1.51%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: -2.08%
H: 0.13%
C: -0.57%
BMY | $48.26 -0.52% 0.04% 12M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT | $21.86 2.73% 2.65% 470K
|
Health Technology
|
| O: 2.56%
H: 1.37%
C: -4.13%
AQST | $3.83 -2.79% -2.87% 1.9M
|
Health Technology
|
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS | $23.78 -1.0% -1.01% 1.6M
|
Health Technology
|
| O: 1.11%
H: 0.96%
C: 0.65%
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-01 (Crawled : 21:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
| Email alert
Add to watchlist
nasdaq pharmaceuticals grants
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-02-01 (Crawled : 21:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: -0.01%
H: 3.56%
C: -1.29%
nasdaq pharmaceuticals grants
X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
Published: 2023-12-09 (Crawled : 20:20) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
| Email alert
Add to watchlist
presentation pharmaceuticals trial
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-04 (Crawled : 21:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 3.43%
H: 9.39%
C: 5.27%
nasdaq pharmaceuticals grants
X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences
Published: 2023-11-10 (Crawled : 13:00) - globenewswire.com
XFOR | $1.31 4.8% 4.58% 2.2M
|
Health Technology
|
| O: 0.22%
H: 3.57%
C: -5.23%
pharmaceuticals
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Last 48 Hours Insiders Buying
KFS P 481 | $8.6 1.06% 0.0% 15K
|
Finance
|
20:30
AINC | $4.83 -1.43% 1.45% 98K
|
Finance
|
20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K
|
Health Technology
|
17:00
TPL P 12 | $586.93 0.52% 0.0% 50K
|
Miscellaneous
|
16:01
HNRA | $2.76 16.95% -1.81% 400K
|
n/a
|
15:02
TGEN | $0.67 39.71% 16K
|
Utilities
|
14:30
RMCF | $3.6492 -7.2% 9.2K
|
Consumer Non-Durables
|
20:10